Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.

Nayak, Anjuli; Casale, Thomas; Miller, S David; Condemi, John; McAlary, Margaret; Fowler-Taylor, Angel; Della Cioppa, Giovanni; Gupta, Niroo

Nayak, Anjuli; Casale, Thomas; Miller, S David; Condemi, John; McAlary, Margaret; Fowler-Taylor, Angel; Della Cioppa, Giovanni; Gupta, Niroo.

Affiliation

Nayak A; Sneeze, Wheeze & Itch Associates, 2010 Jacobssen Drive, Normal, IL 61761, USA.

Allergy Asthma Proc ; 24(5): 323-9, 2003.

Article in En | MEDLINE | ID: mdl-14619332

Subject(s)

Ambrosia/immunology; Anti-Allergic Agents/adverse effects; Antibodies, Anti-Idiotypic/immunology; Antibodies, Monoclonal/adverse effects; Immunoglobulin E/immunology; Pollen/immunology; Rhinitis, Allergic, Seasonal/drug therapy; Adolescent; Adult; Aged; Allergens/immunology; Anti-Allergic Agents/administration & dosage; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Child; Female; Humans; Male; Middle Aged; Omalizumab; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Retreatment/adverse effects; Seasons

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pollen / Immunoglobulin E / Rhinitis, Allergic, Seasonal / Antibodies, Anti-Idiotypic / Anti-Allergic Agents / Ambrosia / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Allergy Asthma Proc Journal subject: ALERGIA E IMUNOLOGIA Year: 2003 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links